Back to search results

Educational Intervention to Improve Clinical Trial Understanding in Minorities

This study is testing an "Educational Intervention" to help minority patients better understand and make decisions about cancer clinical trials. The intervention involves a dedicated, in-person visit with a patient navigator, lasting 30-45 minutes, to address barriers to understanding. The study aims to see if this intervention improves your knowledge and attitudes about clinical trials within four months. You may be eligible if you are at least 18 years old, have advanced or early-stage cancer, and are identified as non-white or Hispanic in your medical records. The study is currently recruiting 240 participants.

Study design
This interventional study plans to enroll 240 participants to test an educational intervention.
What's involved
You would have a dedicated in-person visit with a patient navigator, estimated to last 30-45 minutes.
Compensation
Not stated in the trial record.
Follow-up
Your knowledge and attitudes will be measured up to 4 months after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05701085

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

Recruiting
NAAges 18+InterventionalSupportive care
Case Comprehensive Cancer Center
~240 participants
Updated 2026-04-07 on ClinicalTrials.gov
What's tested:Educational Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in knowledge regarding cancer clinical trials after the intervention
Measured over Up to 4 months
+1 more outcome measured

Conditions

Educational Intervention
Minorities

Explore related trials

Malignant Neoplasm

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Lauren Chiec, MD · PRINCIPAL_INVESTIGATOR · University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Who to contact

Lauren Chiec, MD
[email protected]
216-286-6741
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants must have a diagnosis of either advanced (metastatic) cancer or early stage disease for which they are undergoing oncological work-up, treatment or surveillance
Participants must be at least 18 years of age
Participants have a non-white race or Hispanic ethnicity recorded in their patient demographics in the electronic medical record
Participant must have a life expectancy greater than three months based on the primary oncology team's clinical assessment.
Participants must be able to read and verbally communicate in English.
Participants must provide written informed consent.

What this trial measures

  • Change in knowledge regarding cancer clinical trials after the interventionUp to 4 months

    Change in knowledge regarding cancer clinical trials after the intervention will be assessed by change in Pre and Post Intervention Survey Knowledge Score (scored from Items 1-8) with a higher score correlating to a greater change in knowledge.

  • Change in attitudes regarding cancer clinical trials after the interventionUp to 4 months

    A change in attitude will be recorded using changes in Pre and Post Intervention Survey Attitude Scores (scored from Items 9-21) with a higher score correlating to a greater change in attitude.